FDA
approval
· 2007-03-28
FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
The FDA approved a supplemental application from Hikma Pharmaceuticals USA Inc. for diphenoxylate hydrochloride and atropine sulfate.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)